Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia

Metabolic disease in HIV infection

(2013) Jordan E Lake et al.   LANCET INFECTIOUS DISEASES

Association of Educational, Occupational and Socioeconomic Status with Cardiovascular Risk Factors in Asian Indians: A Cross-Sectional Study

(2012) Rajeev Gupta et al.   PLoS One

High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients

(2011) Aoife G Cotter et al.   AIDS

Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease

(2011) Rachel R. Huxley et al.   CIRCULATION

Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais

(2011) N Edwards-Jackson et al.   HIV MEDICINE

High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia

(2011) Laurent Ferradini et al.   Journal of the International AIDS Society

Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population

(2010) Sylvie Lang et al.   AIDS

Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

(2010) Nina Friis-Møller et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study

(2010) M. Aboud et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study

(2010) Jean-Michel Molina et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women

(2010) Kathryn Anastos et al.   AIDS Research and Therapy

Survival and Quality of Life Among HIV-Positive People on Antiretroviral Therapy in Cambodia

(2009) Guy Morineau et al.   AIDS PATIENT CARE AND STDS

Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)

(2009) Charlotte Lewden et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

(2009) Signe Westring Worm et al.   JOURNAL OF INFECTIOUS DISEASES

Lipid Abnormalities in a Never-Treated HIV-1 Subtype C-Infected African Population

(2009) Carla Maria T. Fourie et al.   LIPIDS

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort

(2008) P. Domingo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Lipoprotein changes in HIV-infected antiretroviral-naïve individuals after starting antiretroviral therapy: ACTG Study A5152s

(2008) James H. Stein et al.   Journal of Clinical Lipidology